As of November 10, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of CervoMed Inc. The largest reported stake is Boger Joshua S', at 20%. 12 filings are on record since August 14, 2025 (Schedule 13D/A, June 15, 2026).
Sell to companies like CervoMed Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Armistice Capital, LLC · Sole voting: 0 · Shared voting: 1,592,863 · Sole dispositive: 0 · Shared dispositive: 1,592,863 · SCHEDULE 13G, 2026-08-14
- · Reporting person: RA Capital Management, L.P. · Sole voting: 0 · Shared voting: 1,266,143 · Sole dispositive: 0 · Shared dispositive: 1,266,143 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Woodline Partners LP · Sole voting: 688,987 · Shared voting: 0 · Sole dispositive: 688,987 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-14
- · Reporting person: CVI Investments, Inc. · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Morgan Stanley · Sole voting: 0 · Shared voting: 10,000 · Sole dispositive: 0 · Shared dispositive: 12,550 · SCHEDULE 13G/A, 2026-07-08
CervoMed Inc. has 12 Schedule 13D or 13G filings on record since 2025-08-14. 4 holders' latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 20% | 2,204,143 | SCHEDULE 13D/A, 2026-06-15 | 2026-06-11 | |
| Armistice Capital, LLC | 9.53% | 1,592,863 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| RA Capital Management, L.P. | 8.6% | 1,266,143 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Woodline Partners LP | 5.1% | 688,987 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| AWM Investment Company, Inc. | 4.2% | 405,165 | SCHEDULE 13G/A, 2026-04-07 | 2026-03-31 |
| 0.1% | 12,550 | SCHEDULE 13G/A, 2026-07-08 | 2026-06-30 | |
| CVI Investments, Inc. | 0% | 0 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
Holding shares or following this stake? See who's behind CervoMed Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on CervoMed Inc. and the records around it.
CervoMed Inc. elsewhere on the record
Companies that share a holder
- Woodline Partners LP also filed stake reports on 19 other companies: Biohaven Ltd. (Aug 2026), Black Rock Coffee Bar, Inc. (Aug 2026), CalciMedica, Inc. (Aug 2026)
- AWM Investment Company, Inc. also filed stake reports on 32 other companies: 908 Devices Inc. (Aug 2026), Brazil Potash Corp. (Aug 2026), EVERSPIN TECHNOLOGIES INC. (Aug 2026)
- CVI Investments, Inc. also filed stake reports on 48 other companies: Pine Tree Acquisition Corp. (Oct 2026), Sunshine Biopharma Inc. (Oct 2026), Outlook Therapeutics, Inc. (Aug 2026)
Watch CervoMed Inc.
Get an email when CervoMed Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on CervoMed Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CervoMed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CervoMed Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Boger Joshua S | 2,204,143 | 0 | 2,204,143 | 0 | SCHEDULE 13D/A, 2026-06-15 |
| Armistice Capital, LLC | 0 | 1,592,863 | 0 | 1,592,863 | SCHEDULE 13G, 2026-08-14 |
| Steven Boyd | 0 | 1,592,863 | 0 | 1,592,863 | SCHEDULE 13G, 2026-08-14 |
| RA Capital Management, L.P. | 0 | 1,266,143 | 0 | 1,266,143 | SCHEDULE 13G/A, 2026-08-14 |
| Peter Kolchinsky | 0 | 1,266,143 | 0 | 1,266,143 | SCHEDULE 13G/A, 2026-08-14 |
| Rajeev Shah | 0 | 1,266,143 | 0 | 1,266,143 | SCHEDULE 13G/A, 2026-08-14 |
| RA Capital Healthcare Fund, L.P. | 0 | 1,266,143 | 0 | 1,266,143 | SCHEDULE 13G/A, 2026-08-14 |
| Woodline Partners LP | 688,987 | 0 | 688,987 | 0 | SCHEDULE 13G, 2026-08-14 |
| Morgan Stanley | 0 | 10,000 | 0 | 12,550 | SCHEDULE 13G/A, 2026-07-08 |
| Morgan Stanley Capital Services LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-07-08 |
| CVI Investments, Inc. | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Heights Capital Management, Inc. | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-08-14 |
The latest filing identifies CervoMed Inc. by CUSIP 15713L109 and gives its principal executive office as 20 Park Plaza, Suite 424, Boston, MA 02116 (SCHEDULE 13G, 2026-08-14).
What the percentages are based on
Row 11 of each Reporting Person's cover page to this Schedule 13G/A sets forth the percentages of the shares of common stock of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.RA Capital Management, L.P., SCHEDULE 13G/A, 2026-08-14
Source of funds (Item 3)
1.Boger Joshua S, SCHEDULE 13D/A, 2026-06-15
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | RA Capital Management, L.P. | 0% | SCHEDULE 13G/A |
| 2025-08-20 | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G/A |
| 2026-02-11 | Morgan Stanley | 5.1% | SCHEDULE 13G |
| 2026-04-07 | AWM Investment Company, Inc. | 4.2% | SCHEDULE 13G/A |
| 2026-05-11 | Morgan Stanley | 8% | SCHEDULE 13G/A |
| 2026-06-15 | Boger Joshua S | 20% | SCHEDULE 13D/A |
| 2026-06-26 | CVI Investments, Inc. | 5.5% | SCHEDULE 13G |
| 2026-07-08 | Morgan Stanley | 0.1% | SCHEDULE 13G/A |
| 2026-08-14 | Woodline Partners LP | 5.1% | SCHEDULE 13G |
| 2026-08-14 | Armistice Capital, LLC | 9.53% | SCHEDULE 13G |
| 2026-08-14 | RA Capital Management, L.P. | 8.6% | SCHEDULE 13G/A |
| 2026-08-14 | CVI Investments, Inc. | 0% | SCHEDULE 13G/A |
Questions about who owns CervoMed Inc.
Who owns CervoMed Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of CervoMed Inc.: Boger Joshua S (20%, Schedule 13D/A, filed 2026-06-15), Armistice Capital, LLC (9.53%, Schedule 13G, filed 2026-08-14), RA Capital Management, L.P. (8.6%, Schedule 13G/A, filed 2026-08-14) and Woodline Partners LP (5.1%, Schedule 13G, filed 2026-08-14).
Who are the largest shareholders of CervoMed Inc.?
By the share each holder's latest filing reports, the largest holders of CervoMed Inc. on this page are Boger Joshua S (20%), Armistice Capital, LLC (9.53%) and RA Capital Management, L.P. (8.6%).
When did Boger Joshua S buy into CervoMed Inc.?
The filings give report dates, not purchase dates. The earliest filing from Boger Joshua S on this page is the Schedule 13D/A, filed 2026-06-15, reporting 20%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for CervoMed Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.